SEARCH

SEARCH BY CITATION

References

  • 1
    El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995;332: 983987.
  • 2
    von Hertzen H, Honkanen H, Piaggio G, et al. WHO multinational study of three misoprostol regimens after mifepristone for early medical abortion. I: Efficacy. Br J Obstet Gynaecol 2003;110: 808818.
  • 3
    World Health Organization. Task Force on Post-Ovulatory Methods of Fertility Regulation. Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomised trial. Br J Obstet Gynaecol 2000;107: 524530.
  • 4
    Ngai SW, Tang OS, Ho PC. Randomized comparison of vaginal (200 microg every 3 h) and oral (400 microg every 3 h) misoprostol when combined with mifepristone in termination of second trimester pregnancy. Hum Reprod 2000;15: 22052208.
  • 5
    Schaff EA, Stadalius LS, Eisinger SH, Franks P. Vaginal misoprostol administered at home after mifepristone (RU486) for abortion. J Fam Pract 1997;44: 353360.
  • 6
    Tang OS, Gao PP, Cheng L, Lee S, Ho PC. Pilot study on the use of a two-week course of oral misoprostol in patients after termination of pregnancy with mifepristone and misoprostol. Contraception 1998;57: 8991.
  • 7
    Gouk EV, Lincoln K, Khair A, Haslock J, Knight J, Cruickshank DJ. Medical termination of pregnancy at 63 to 83 days gestation. Br J Obstet Gynaecol 1999;106: 535539.
  • 8
    Weeks A, Stewart P. The use of low dose mifepristone and vaginal misoprostol for first trimester termination of pregnancy. Br J Fam Plan 1995;106: 8586.
  • 9
    Harper C, Ellertson C, Winikoff B. Could American women use mifepristone–misoprostol pills safely with less medical supervision? Contraception 2002;65: 133142.
  • 10
    Elul B, Hajri S, Ngoc NN, et al. Can women in less-developed countries use a simplified medical abortion regimen? Lancet 2001;357: 14021405.
  • 11
    AHFS. AHFS Drug Information. Bethesda: American Society of Health-System Pharmacists, 2002: 28492855.
  • 12
    Ayres-de-Campos D, Teixeira-da-Silva J, Campos I, Patricio B. Vaginal misoprostol in the management of first-trimester missed abortions. Int J Gynaecol Obstet 2000;71: 5357.
  • 13
    Wong KS, Ngai CS, Yeo EL, Tang LC, Ho PC. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial. Hum Reprod 2000;15: 709712.
  • 14
    WHO-UMC (WHO Collaborating Centre for International Drug Monitoring). Available: http://www.who-umc.org. Search on adverse reactions to misoprostol, performed in May 2002.
  • 15
    Ramsey PS, Hogg BB, Savage KG, Winkler DD, Owen J. Cardiovascular effects of intravaginal misoprostol in the mid trimester of pregnancy. Am J Obstet Gynecol 2000;183: 11001102.
  • 16
    Gemzell Danielsson K, Marions L, Rodriguez A, Spur BW, Wong PY, Bygdeman M. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol 1999;93: 275280.
  • 17
    Jensen JT, Harvey SM, Beckman LJ. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study. Am J Obstet Gynecol 2000;182: 12921299.
  • 18
    Winikoff B, Sivin I, Coyaji KJ, et al. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone–misoprostol versus surgical abortion. Am J Obstet Gynecol 1997;176: 431437.
  • 19
    Henshaw RC, Naji SA, Russell IT, Templeton AA. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment. BMJ 1993;307: 714717.
  • 20
    Schaff EA, Fielding SL, Eisinger SH, Stadalius LS, Fuller L. Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days. Contraception 2000;61: 4146.